West Pharmaceutical Services (WST) Inventory Average (2010 - 2026)

West Pharmaceutical Services' Inventory Average history runs 17 years deep, the most recent figure standing at $448.2 million for Q1 2026.

• In Q1 2026, Inventory Average rose 17.08% year-over-year to $448.2 million; the TTM figure through Mar 2026 stood at $448.2 million (up 17.08% YoY), while the FY2025 annual figure was $410.4 million, up 1.13% from the prior year.
• Inventory Average came in at $448.2 million for Q1 2026 at West Pharmaceutical Services, up from $441.0 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $448.2 million in Q1 2026 to a low of $382.8 million in Q1 2025.
• A 5-year average of $420.8 million and a median of $424.6 million in 2024 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average gained 26.35% in 2022 and declined 11.44% in 2025, its largest moves.
• West Pharmaceutical Services' Inventory Average stood at $414.0 million in 2022, then increased by 4.66% to $433.2 million in 2023, then dropped by 10.19% to $389.1 million in 2024, then rose by 13.33% to $441.0 million in 2025, then gained by 1.66% to $448.2 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $448.2 million, $441.0 million, and $429.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison